nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—HTR2B—Raloxifene—osteoporosis	0.344	0.494	CbGbCtD
Methylergometrine—CYP3A4—Estropipate—osteoporosis	0.064	0.0918	CbGbCtD
Methylergometrine—CYP3A4—Calcitriol—osteoporosis	0.064	0.0918	CbGbCtD
Methylergometrine—CYP3A4—Ergocalciferol—osteoporosis	0.0511	0.0734	CbGbCtD
Methylergometrine—CYP3A4—Raloxifene—osteoporosis	0.0427	0.0613	CbGbCtD
Methylergometrine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0412	0.0592	CbGbCtD
Methylergometrine—CYP3A4—Cholecalciferol—osteoporosis	0.033	0.0473	CbGbCtD
Methylergometrine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0303	0.0434	CbGbCtD
Methylergometrine—CYP3A4—Estradiol—osteoporosis	0.0266	0.0381	CbGbCtD
Methylergometrine—Vasospasm—Calcium Acetate—osteoporosis	0.0187	0.0715	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Etidronic acid—osteoporosis	0.00385	0.0147	CcSEcCtD
Methylergometrine—Haematuria—Calcium Acetate—osteoporosis	0.0034	0.013	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Estropipate—osteoporosis	0.00333	0.0127	CcSEcCtD
Methylergometrine—Bradycardia—Calcium Acetate—osteoporosis	0.00326	0.0125	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Raloxifene—osteoporosis	0.00322	0.0123	CcSEcCtD
Methylergometrine—Thrombophlebitis—Estropipate—osteoporosis	0.00304	0.0116	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Estropipate—osteoporosis	0.00268	0.0103	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Risedronate—osteoporosis	0.00263	0.0101	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Raloxifene—osteoporosis	0.0026	0.00996	CcSEcCtD
Methylergometrine—Thrombophlebitis—Pamidronate—osteoporosis	0.00228	0.00874	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Conjugated Estrogens—osteoporosis	0.0022	0.00842	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Ethinyl Estradiol—osteoporosis	0.00217	0.00833	CcSEcCtD
Methylergometrine—Hypertension—Ergocalciferol—osteoporosis	0.00213	0.00815	CcSEcCtD
Methylergometrine—Hypotension—Calcium Acetate—osteoporosis	0.00213	0.00815	CcSEcCtD
Methylergometrine—Hallucination—Etidronic acid—osteoporosis	0.00209	0.00802	CcSEcCtD
Methylergometrine—Paraesthesia—Calcium Acetate—osteoporosis	0.00204	0.00783	CcSEcCtD
Methylergometrine—Thrombophlebitis—Conjugated Estrogens—osteoporosis	0.00201	0.00769	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Conjugated Estrogens—osteoporosis	0.00177	0.00679	CcSEcCtD
Methylergometrine—Muscle spasms—Etidronic acid—osteoporosis	0.00176	0.00674	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Estradiol—osteoporosis	0.00176	0.00674	CcSEcCtD
Methylergometrine—Angina pectoris—Risedronate—osteoporosis	0.00175	0.0067	CcSEcCtD
Methylergometrine—Cardiac disorder—Estropipate—osteoporosis	0.00169	0.00647	CcSEcCtD
Methylergometrine—Sweating increased—Pamidronate—osteoporosis	0.00166	0.00637	CcSEcCtD
Methylergometrine—Cardiac disorder—Raloxifene—osteoporosis	0.00163	0.00627	CcSEcCtD
Methylergometrine—Cardiac disorder—Ibandronate—osteoporosis	0.00162	0.0062	CcSEcCtD
Methylergometrine—Thrombophlebitis—Estradiol—osteoporosis	0.00161	0.00615	CcSEcCtD
Methylergometrine—Diarrhoea—Calcium Acetate—osteoporosis	0.00156	0.00596	CcSEcCtD
Methylergometrine—Nasal congestion—Estradiol—osteoporosis	0.00153	0.00585	CcSEcCtD
Methylergometrine—Muscle spasms—Estropipate—osteoporosis	0.00152	0.00583	CcSEcCtD
Methylergometrine—Sweating increased—Zoledronate—osteoporosis	0.00152	0.00582	CcSEcCtD
Methylergometrine—Dizziness—Calcium Acetate—osteoporosis	0.0015	0.00576	CcSEcCtD
Methylergometrine—Muscle spasms—Alendronate—osteoporosis	0.0015	0.00574	CcSEcCtD
Methylergometrine—Muscle spasms—Raloxifene—osteoporosis	0.00147	0.00565	CcSEcCtD
Methylergometrine—Sweating increased—Conjugated Estrogens—osteoporosis	0.00146	0.0056	CcSEcCtD
Methylergometrine—Muscle spasms—Ibandronate—osteoporosis	0.00146	0.00559	CcSEcCtD
Methylergometrine—Haematuria—Pamidronate—osteoporosis	0.00145	0.00556	CcSEcCtD
Methylergometrine—Vomiting—Calcium Acetate—osteoporosis	0.00145	0.00554	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Estradiol—osteoporosis	0.00142	0.00544	CcSEcCtD
Methylergometrine—Palpitations—Estropipate—osteoporosis	0.0014	0.00536	CcSEcCtD
Methylergometrine—Nausea—Calcium Acetate—osteoporosis	0.00135	0.00518	CcSEcCtD
Methylergometrine—Palpitations—Ibandronate—osteoporosis	0.00134	0.00514	CcSEcCtD
Methylergometrine—Paraesthesia—Etidronic acid—osteoporosis	0.00134	0.00514	CcSEcCtD
Methylergometrine—Tinnitus—Risedronate—osteoporosis	0.00134	0.00514	CcSEcCtD
Methylergometrine—Cardiac disorder—Risedronate—osteoporosis	0.00133	0.00511	CcSEcCtD
Methylergometrine—Chest pain—Alendronate—osteoporosis	0.00133	0.00509	CcSEcCtD
Methylergometrine—Haematuria—Zoledronate—osteoporosis	0.00133	0.00508	CcSEcCtD
Methylergometrine—Hypertension—Ibandronate—osteoporosis	0.00131	0.00502	CcSEcCtD
Methylergometrine—Chest pain—Raloxifene—osteoporosis	0.00131	0.005	CcSEcCtD
Methylergometrine—Chest pain—Ibandronate—osteoporosis	0.00129	0.00495	CcSEcCtD
Methylergometrine—Anaphylactic shock—Estropipate—osteoporosis	0.00129	0.00495	CcSEcCtD
Methylergometrine—Convulsion—Calcitriol—osteoporosis	0.00129	0.00493	CcSEcCtD
Methylergometrine—Hypertension—Calcitriol—osteoporosis	0.00128	0.00492	CcSEcCtD
Methylergometrine—Bradycardia—Zoledronate—osteoporosis	0.00127	0.00487	CcSEcCtD
Methylergometrine—Cardiac disorder—Pamidronate—osteoporosis	0.00127	0.00486	CcSEcCtD
Methylergometrine—Nervous system disorder—Estropipate—osteoporosis	0.00127	0.00486	CcSEcCtD
Methylergometrine—Chest pain—Calcitriol—osteoporosis	0.00127	0.00485	CcSEcCtD
Methylergometrine—Anaphylactic shock—Ibandronate—osteoporosis	0.00124	0.00475	CcSEcCtD
Methylergometrine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.00123	0.00473	CcSEcCtD
Methylergometrine—Nervous system disorder—Raloxifene—osteoporosis	0.00123	0.0047	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00122	0.00468	CcSEcCtD
Methylergometrine—Nervous system disorder—Ibandronate—osteoporosis	0.00122	0.00466	CcSEcCtD
Methylergometrine—Anaphylactic shock—Calcitriol—osteoporosis	0.00121	0.00465	CcSEcCtD
Methylergometrine—Hyperhidrosis—Raloxifene—osteoporosis	0.00121	0.00464	CcSEcCtD
Methylergometrine—Muscle spasms—Risedronate—osteoporosis	0.0012	0.00461	CcSEcCtD
Methylergometrine—Hyperhidrosis—Ibandronate—osteoporosis	0.0012	0.00459	CcSEcCtD
Methylergometrine—Nausea—Ergocalciferol—osteoporosis	0.00119	0.00457	CcSEcCtD
Methylergometrine—Abdominal pain—Etidronic acid—osteoporosis	0.00118	0.00452	CcSEcCtD
Methylergometrine—Sweating increased—Estradiol—osteoporosis	0.00117	0.00449	CcSEcCtD
Methylergometrine—Paraesthesia—Estropipate—osteoporosis	0.00116	0.00445	CcSEcCtD
Methylergometrine—Cardiac disorder—Zoledronate—osteoporosis	0.00116	0.00444	CcSEcCtD
Methylergometrine—Muscle spasms—Pamidronate—osteoporosis	0.00114	0.00438	CcSEcCtD
Methylergometrine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00112	0.00427	CcSEcCtD
Methylergometrine—Paraesthesia—Ibandronate—osteoporosis	0.00111	0.00426	CcSEcCtD
Methylergometrine—Hypertension—Risedronate—osteoporosis	0.00108	0.00414	CcSEcCtD
Methylergometrine—Chest pain—Risedronate—osteoporosis	0.00107	0.00408	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Estropipate—osteoporosis	0.00106	0.00405	CcSEcCtD
Methylergometrine—Muscle spasms—Zoledronate—osteoporosis	0.00104	0.004	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Alendronate—osteoporosis	0.00104	0.00399	CcSEcCtD
Methylergometrine—Convulsion—Pamidronate—osteoporosis	0.00103	0.00395	CcSEcCtD
Methylergometrine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00103	0.00394	CcSEcCtD
Methylergometrine—Hypertension—Pamidronate—osteoporosis	0.00103	0.00393	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00102	0.00392	CcSEcCtD
Methylergometrine—Diarrhoea—Etidronic acid—osteoporosis	0.00102	0.00392	CcSEcCtD
Methylergometrine—Haematuria—Estradiol—osteoporosis	0.00102	0.00391	CcSEcCtD
Methylergometrine—Abdominal pain—Estropipate—osteoporosis	0.00102	0.00391	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00101	0.00388	CcSEcCtD
Methylergometrine—Abdominal pain—Alendronate—osteoporosis	0.00101	0.00386	CcSEcCtD
Methylergometrine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00101	0.00385	CcSEcCtD
Methylergometrine—Nervous system disorder—Risedronate—osteoporosis	0.001	0.00384	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000992	0.0038	CcSEcCtD
Methylergometrine—Abdominal pain—Raloxifene—osteoporosis	0.000989	0.00379	CcSEcCtD
Methylergometrine—Abdominal pain—Ibandronate—osteoporosis	0.000979	0.00375	CcSEcCtD
Methylergometrine—Anaphylactic shock—Pamidronate—osteoporosis	0.000971	0.00372	CcSEcCtD
Methylergometrine—Palpitations—Zoledronate—osteoporosis	0.00096	0.00368	CcSEcCtD
Methylergometrine—Abdominal pain—Calcitriol—osteoporosis	0.000959	0.00367	CcSEcCtD
Methylergometrine—Nervous system disorder—Pamidronate—osteoporosis	0.000952	0.00365	CcSEcCtD
Methylergometrine—Vomiting—Etidronic acid—osteoporosis	0.00095	0.00364	CcSEcCtD
Methylergometrine—Tachycardia—Pamidronate—osteoporosis	0.000947	0.00363	CcSEcCtD
Methylergometrine—Rash—Etidronic acid—osteoporosis	0.000942	0.00361	CcSEcCtD
Methylergometrine—Convulsion—Zoledronate—osteoporosis	0.000941	0.00361	CcSEcCtD
Methylergometrine—Dermatitis—Etidronic acid—osteoporosis	0.000941	0.00361	CcSEcCtD
Methylergometrine—Hyperhidrosis—Pamidronate—osteoporosis	0.000938	0.0036	CcSEcCtD
Methylergometrine—Hypertension—Zoledronate—osteoporosis	0.000938	0.00359	CcSEcCtD
Methylergometrine—Headache—Etidronic acid—osteoporosis	0.000936	0.00359	CcSEcCtD
Methylergometrine—Chest pain—Zoledronate—osteoporosis	0.000925	0.00354	CcSEcCtD
Methylergometrine—Palpitations—Conjugated Estrogens—osteoporosis	0.000924	0.00354	CcSEcCtD
Methylergometrine—Paraesthesia—Risedronate—osteoporosis	0.000917	0.00351	CcSEcCtD
Methylergometrine—Dyspnoea—Risedronate—osteoporosis	0.00091	0.00349	CcSEcCtD
Methylergometrine—Hypotension—Pamidronate—osteoporosis	0.000907	0.00348	CcSEcCtD
Methylergometrine—Convulsion—Conjugated Estrogens—osteoporosis	0.000906	0.00347	CcSEcCtD
Methylergometrine—Tinnitus—Estradiol—osteoporosis	0.000897	0.00344	CcSEcCtD
Methylergometrine—Cardiac disorder—Estradiol—osteoporosis	0.000893	0.00342	CcSEcCtD
Methylergometrine—Chest pain—Conjugated Estrogens—osteoporosis	0.000891	0.00341	CcSEcCtD
Methylergometrine—Nausea—Etidronic acid—osteoporosis	0.000887	0.0034	CcSEcCtD
Methylergometrine—Anaphylactic shock—Zoledronate—osteoporosis	0.000887	0.0034	CcSEcCtD
Methylergometrine—Diarrhoea—Estropipate—osteoporosis	0.000884	0.00339	CcSEcCtD
Methylergometrine—Paraesthesia—Pamidronate—osteoporosis	0.000872	0.00334	CcSEcCtD
Methylergometrine—Diarrhoea—Alendronate—osteoporosis	0.000871	0.00334	CcSEcCtD
Methylergometrine—Nervous system disorder—Zoledronate—osteoporosis	0.00087	0.00333	CcSEcCtD
Methylergometrine—Dyspnoea—Pamidronate—osteoporosis	0.000865	0.00332	CcSEcCtD
Methylergometrine—Tachycardia—Zoledronate—osteoporosis	0.000865	0.00332	CcSEcCtD
Methylergometrine—Hyperhidrosis—Zoledronate—osteoporosis	0.000857	0.00328	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000856	0.00328	CcSEcCtD
Methylergometrine—Diarrhoea—Raloxifene—osteoporosis	0.000856	0.00328	CcSEcCtD
Methylergometrine—Dizziness—Estropipate—osteoporosis	0.000854	0.00327	CcSEcCtD
Methylergometrine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000854	0.00327	CcSEcCtD
Methylergometrine—Diarrhoea—Ibandronate—osteoporosis	0.000848	0.00325	CcSEcCtD
Methylergometrine—Dizziness—Alendronate—osteoporosis	0.000842	0.00322	CcSEcCtD
Methylergometrine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000837	0.00321	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Risedronate—osteoporosis	0.000835	0.0032	CcSEcCtD
Methylergometrine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000833	0.00319	CcSEcCtD
Methylergometrine—Diarrhoea—Calcitriol—osteoporosis	0.00083	0.00318	CcSEcCtD
Methylergometrine—Hypotension—Zoledronate—osteoporosis	0.000829	0.00317	CcSEcCtD
Methylergometrine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000828	0.00317	CcSEcCtD
Methylergometrine—Dizziness—Raloxifene—osteoporosis	0.000828	0.00317	CcSEcCtD
Methylergometrine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000825	0.00316	CcSEcCtD
Methylergometrine—Vomiting—Estropipate—osteoporosis	0.000822	0.00315	CcSEcCtD
Methylergometrine—Dizziness—Ibandronate—osteoporosis	0.000819	0.00314	CcSEcCtD
Methylergometrine—Rash—Estropipate—osteoporosis	0.000815	0.00312	CcSEcCtD
Methylergometrine—Dermatitis—Estropipate—osteoporosis	0.000814	0.00312	CcSEcCtD
Methylergometrine—Headache—Estropipate—osteoporosis	0.000809	0.0031	CcSEcCtD
Methylergometrine—Vomiting—Alendronate—osteoporosis	0.000809	0.0031	CcSEcCtD
Methylergometrine—Abdominal pain—Risedronate—osteoporosis	0.000807	0.00309	CcSEcCtD
Methylergometrine—Muscle spasms—Estradiol—osteoporosis	0.000805	0.00308	CcSEcCtD
Methylergometrine—Rash—Alendronate—osteoporosis	0.000802	0.00307	CcSEcCtD
Methylergometrine—Dermatitis—Alendronate—osteoporosis	0.000802	0.00307	CcSEcCtD
Methylergometrine—Hypotension—Conjugated Estrogens—osteoporosis	0.000798	0.00306	CcSEcCtD
Methylergometrine—Headache—Alendronate—osteoporosis	0.000797	0.00306	CcSEcCtD
Methylergometrine—Paraesthesia—Zoledronate—osteoporosis	0.000796	0.00305	CcSEcCtD
Methylergometrine—Vomiting—Raloxifene—osteoporosis	0.000796	0.00305	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000794	0.00304	CcSEcCtD
Methylergometrine—Dyspnoea—Zoledronate—osteoporosis	0.00079	0.00303	CcSEcCtD
Methylergometrine—Rash—Raloxifene—osteoporosis	0.000789	0.00302	CcSEcCtD
Methylergometrine—Dermatitis—Raloxifene—osteoporosis	0.000788	0.00302	CcSEcCtD
Methylergometrine—Vomiting—Ibandronate—osteoporosis	0.000788	0.00302	CcSEcCtD
Methylergometrine—Headache—Raloxifene—osteoporosis	0.000784	0.003	CcSEcCtD
Methylergometrine—Rash—Ibandronate—osteoporosis	0.000781	0.00299	CcSEcCtD
Methylergometrine—Dermatitis—Ibandronate—osteoporosis	0.000781	0.00299	CcSEcCtD
Methylergometrine—Headache—Ibandronate—osteoporosis	0.000776	0.00297	CcSEcCtD
Methylergometrine—Vomiting—Calcitriol—osteoporosis	0.000771	0.00296	CcSEcCtD
Methylergometrine—Nausea—Estropipate—osteoporosis	0.000767	0.00294	CcSEcCtD
Methylergometrine—Abdominal pain—Pamidronate—osteoporosis	0.000767	0.00294	CcSEcCtD
Methylergometrine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000767	0.00294	CcSEcCtD
Methylergometrine—Rash—Calcitriol—osteoporosis	0.000765	0.00293	CcSEcCtD
Methylergometrine—Dermatitis—Calcitriol—osteoporosis	0.000764	0.00293	CcSEcCtD
Methylergometrine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000761	0.00292	CcSEcCtD
Methylergometrine—Headache—Calcitriol—osteoporosis	0.00076	0.00291	CcSEcCtD
Methylergometrine—Nausea—Alendronate—osteoporosis	0.000756	0.0029	CcSEcCtD
Methylergometrine—Nausea—Raloxifene—osteoporosis	0.000743	0.00285	CcSEcCtD
Methylergometrine—Palpitations—Estradiol—osteoporosis	0.00074	0.00284	CcSEcCtD
Methylergometrine—Nausea—Ibandronate—osteoporosis	0.000736	0.00282	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000725	0.00278	CcSEcCtD
Methylergometrine—Hypertension—Estradiol—osteoporosis	0.000723	0.00277	CcSEcCtD
Methylergometrine—Nausea—Calcitriol—osteoporosis	0.00072	0.00276	CcSEcCtD
Methylergometrine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000717	0.00275	CcSEcCtD
Methylergometrine—Chest pain—Estradiol—osteoporosis	0.000713	0.00273	CcSEcCtD
Methylergometrine—Abdominal pain—Zoledronate—osteoporosis	0.000701	0.00269	CcSEcCtD
Methylergometrine—Diarrhoea—Risedronate—osteoporosis	0.000699	0.00268	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000698	0.00268	CcSEcCtD
Methylergometrine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000693	0.00265	CcSEcCtD
Methylergometrine—Anaphylactic shock—Estradiol—osteoporosis	0.000683	0.00262	CcSEcCtD
Methylergometrine—Dizziness—Risedronate—osteoporosis	0.000675	0.00259	CcSEcCtD
Methylergometrine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000675	0.00259	CcSEcCtD
Methylergometrine—Nervous system disorder—Estradiol—osteoporosis	0.00067	0.00257	CcSEcCtD
Methylergometrine—Tachycardia—Estradiol—osteoporosis	0.000667	0.00256	CcSEcCtD
Methylergometrine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000666	0.00255	CcSEcCtD
Methylergometrine—Diarrhoea—Pamidronate—osteoporosis	0.000664	0.00255	CcSEcCtD
Methylergometrine—Hyperhidrosis—Estradiol—osteoporosis	0.000661	0.00253	CcSEcCtD
Methylergometrine—Rash—Ethinyl Estradiol—osteoporosis	0.00066	0.00253	CcSEcCtD
Methylergometrine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00066	0.00253	CcSEcCtD
Methylergometrine—Headache—Ethinyl Estradiol—osteoporosis	0.000656	0.00251	CcSEcCtD
Methylergometrine—Vomiting—Risedronate—osteoporosis	0.000649	0.00249	CcSEcCtD
Methylergometrine—Rash—Risedronate—osteoporosis	0.000644	0.00247	CcSEcCtD
Methylergometrine—Dermatitis—Risedronate—osteoporosis	0.000643	0.00246	CcSEcCtD
Methylergometrine—Dizziness—Pamidronate—osteoporosis	0.000642	0.00246	CcSEcCtD
Methylergometrine—Headache—Risedronate—osteoporosis	0.00064	0.00245	CcSEcCtD
Methylergometrine—Nausea—Ethinyl Estradiol—osteoporosis	0.000622	0.00238	CcSEcCtD
Methylergometrine—Vomiting—Pamidronate—osteoporosis	0.000617	0.00237	CcSEcCtD
Methylergometrine—Paraesthesia—Estradiol—osteoporosis	0.000614	0.00235	CcSEcCtD
Methylergometrine—Rash—Pamidronate—osteoporosis	0.000612	0.00235	CcSEcCtD
Methylergometrine—Dermatitis—Pamidronate—osteoporosis	0.000611	0.00234	CcSEcCtD
Methylergometrine—Dyspnoea—Estradiol—osteoporosis	0.000609	0.00233	CcSEcCtD
Methylergometrine—Headache—Pamidronate—osteoporosis	0.000608	0.00233	CcSEcCtD
Methylergometrine—Diarrhoea—Zoledronate—osteoporosis	0.000607	0.00232	CcSEcCtD
Methylergometrine—Nausea—Risedronate—osteoporosis	0.000607	0.00232	CcSEcCtD
Methylergometrine—Dizziness—Zoledronate—osteoporosis	0.000586	0.00225	CcSEcCtD
Methylergometrine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000584	0.00224	CcSEcCtD
Methylergometrine—Nausea—Pamidronate—osteoporosis	0.000577	0.00221	CcSEcCtD
Methylergometrine—Dizziness—Conjugated Estrogens—osteoporosis	0.000565	0.00216	CcSEcCtD
Methylergometrine—Vomiting—Zoledronate—osteoporosis	0.000564	0.00216	CcSEcCtD
Methylergometrine—Rash—Zoledronate—osteoporosis	0.000559	0.00214	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Estradiol—osteoporosis	0.000559	0.00214	CcSEcCtD
Methylergometrine—Dermatitis—Zoledronate—osteoporosis	0.000559	0.00214	CcSEcCtD
Methylergometrine—Headache—Zoledronate—osteoporosis	0.000555	0.00213	CcSEcCtD
Methylergometrine—Vomiting—Conjugated Estrogens—osteoporosis	0.000543	0.00208	CcSEcCtD
Methylergometrine—Abdominal pain—Estradiol—osteoporosis	0.00054	0.00207	CcSEcCtD
Methylergometrine—Rash—Conjugated Estrogens—osteoporosis	0.000538	0.00206	CcSEcCtD
Methylergometrine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000538	0.00206	CcSEcCtD
Methylergometrine—Headache—Conjugated Estrogens—osteoporosis	0.000535	0.00205	CcSEcCtD
Methylergometrine—Nausea—Zoledronate—osteoporosis	0.000527	0.00202	CcSEcCtD
Methylergometrine—Nausea—Conjugated Estrogens—osteoporosis	0.000507	0.00194	CcSEcCtD
Methylergometrine—Diarrhoea—Estradiol—osteoporosis	0.000468	0.00179	CcSEcCtD
Methylergometrine—Dizziness—Estradiol—osteoporosis	0.000452	0.00173	CcSEcCtD
Methylergometrine—Vomiting—Estradiol—osteoporosis	0.000434	0.00166	CcSEcCtD
Methylergometrine—Rash—Estradiol—osteoporosis	0.000431	0.00165	CcSEcCtD
Methylergometrine—Dermatitis—Estradiol—osteoporosis	0.00043	0.00165	CcSEcCtD
Methylergometrine—Headache—Estradiol—osteoporosis	0.000428	0.00164	CcSEcCtD
Methylergometrine—Nausea—Estradiol—osteoporosis	0.000406	0.00156	CcSEcCtD
Methylergometrine—HTR1F—Signaling Pathways—FGB—osteoporosis	5.81e-05	0.00137	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PTH—osteoporosis	5.75e-05	0.00136	CbGpPWpGaD
Methylergometrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.75e-05	0.00136	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CALCA—osteoporosis	5.73e-05	0.00135	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.62e-05	0.00133	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CALCR—osteoporosis	5.62e-05	0.00133	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTH1R—osteoporosis	5.62e-05	0.00133	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—LRP6—osteoporosis	5.61e-05	0.00132	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CNR2—osteoporosis	5.6e-05	0.00132	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PSMA2—osteoporosis	5.6e-05	0.00132	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PSMA5—osteoporosis	5.6e-05	0.00132	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PTHLH—osteoporosis	5.6e-05	0.00132	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—BMP2—osteoporosis	5.6e-05	0.00132	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—PTHLH—osteoporosis	5.57e-05	0.00131	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PTH—osteoporosis	5.5e-05	0.0013	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—FGB—osteoporosis	5.48e-05	0.00129	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CALCA—osteoporosis	5.4e-05	0.00127	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CNR2—osteoporosis	5.36e-05	0.00126	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—POMC—osteoporosis	5.3e-05	0.00125	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PSMA5—osteoporosis	5.29e-05	0.00125	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PSMA2—osteoporosis	5.29e-05	0.00125	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—WNT1—osteoporosis	5.27e-05	0.00124	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PTHLH—osteoporosis	5.25e-05	0.00124	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CALCA—osteoporosis	5.22e-05	0.00123	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CALCA—osteoporosis	5.2e-05	0.00123	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MGLL—osteoporosis	5.14e-05	0.00121	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—POMC—osteoporosis	5.09e-05	0.0012	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.08e-05	0.0012	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TLN1—osteoporosis	5.02e-05	0.00118	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LRP5—osteoporosis	5.02e-05	0.00118	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.01e-05	0.00118	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—POMC—osteoporosis	5e-05	0.00118	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PTH—osteoporosis	4.99e-05	0.00118	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CALCA—osteoporosis	4.93e-05	0.00116	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CALCA—osteoporosis	4.9e-05	0.00116	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.88e-05	0.00115	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CNR2—osteoporosis	4.87e-05	0.00115	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—POMC—osteoporosis	4.81e-05	0.00113	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LRP6—osteoporosis	4.8e-05	0.00113	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PTHLH—osteoporosis	4.77e-05	0.00112	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—KL—osteoporosis	4.74e-05	0.00112	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TLN1—osteoporosis	4.73e-05	0.00112	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—POMC—osteoporosis	4.63e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CALCA—osteoporosis	4.62e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—TNF—osteoporosis	4.58e-05	0.00108	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—WNT1—osteoporosis	4.58e-05	0.00108	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PTHLH—osteoporosis	4.56e-05	0.00108	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL6R—osteoporosis	4.51e-05	0.00107	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—KL—osteoporosis	4.47e-05	0.00106	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MGLL—osteoporosis	4.46e-05	0.00105	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—POMC—osteoporosis	4.36e-05	0.00103	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LRP5—osteoporosis	4.35e-05	0.00103	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—P4HB—osteoporosis	4.33e-05	0.00102	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—POMC—osteoporosis	4.28e-05	0.00101	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL6R—osteoporosis	4.26e-05	0.001	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PTH—osteoporosis	4.21e-05	0.000994	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CALCA—osteoporosis	4.2e-05	0.00099	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LRP6—osteoporosis	4.17e-05	0.000983	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RAP1A—osteoporosis	4.14e-05	0.000977	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PTHLH—osteoporosis	4.14e-05	0.000977	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CNR2—osteoporosis	4.1e-05	0.000969	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.09e-05	0.000964	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—P4HB—osteoporosis	4.08e-05	0.000964	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—ADCY5—osteoporosis	4.07e-05	0.000961	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—IL6—osteoporosis	4.07e-05	0.00096	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TLN1—osteoporosis	4.05e-05	0.000956	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NFATC1—osteoporosis	4.04e-05	0.000953	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CALCA—osteoporosis	4.01e-05	0.000947	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DKK1—osteoporosis	4.01e-05	0.000945	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PTH—osteoporosis	3.97e-05	0.000937	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RAP1A—osteoporosis	3.9e-05	0.000921	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CNR2—osteoporosis	3.87e-05	0.000913	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—WNT1—osteoporosis	3.86e-05	0.000911	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—ADCY5—osteoporosis	3.84e-05	0.000907	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NFATC1—osteoporosis	3.81e-05	0.000899	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DKK1—osteoporosis	3.78e-05	0.000892	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGA—osteoporosis	3.75e-05	0.000886	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ADCY5—osteoporosis	3.72e-05	0.000877	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—POMC—osteoporosis	3.71e-05	0.000877	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL6—osteoporosis	3.7e-05	0.000873	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—ADCY5—osteoporosis	3.7e-05	0.000873	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CALCA—osteoporosis	3.64e-05	0.00086	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—WNT1—osteoporosis	3.64e-05	0.000859	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SPP1—osteoporosis	3.59e-05	0.000848	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGA—osteoporosis	3.54e-05	0.000835	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TLN1—osteoporosis	3.52e-05	0.00083	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ADCY5—osteoporosis	3.5e-05	0.000827	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—P4HB—osteoporosis	3.49e-05	0.000824	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PTHLH—osteoporosis	3.49e-05	0.000824	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—BMP2—osteoporosis	3.49e-05	0.000824	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—ADCY5—osteoporosis	3.49e-05	0.000823	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGB—osteoporosis	3.41e-05	0.000806	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTH—osteoporosis	3.4e-05	0.000802	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SPP1—osteoporosis	3.39e-05	0.0008	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RAP1A—osteoporosis	3.34e-05	0.000788	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CNR2—osteoporosis	3.31e-05	0.000781	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PSMA2—osteoporosis	3.3e-05	0.000778	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PSMA5—osteoporosis	3.3e-05	0.000778	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	3.3e-05	0.000778	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PTHLH—osteoporosis	3.29e-05	0.000777	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—BMP2—osteoporosis	3.29e-05	0.000777	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—ADCY5—osteoporosis	3.29e-05	0.000776	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NFATC1—osteoporosis	3.26e-05	0.000769	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IRS2—osteoporosis	3.25e-05	0.000767	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DKK1—osteoporosis	3.23e-05	0.000763	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGB—osteoporosis	3.22e-05	0.00076	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—LEP—osteoporosis	3.18e-05	0.000751	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—WNT1—osteoporosis	3.11e-05	0.000735	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PSMA5—osteoporosis	3.11e-05	0.000734	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PSMA2—osteoporosis	3.11e-05	0.000734	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CALCA—osteoporosis	3.07e-05	0.000725	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IRS2—osteoporosis	3.07e-05	0.000724	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—POMC—osteoporosis	3.05e-05	0.00072	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ESR1—osteoporosis	3.04e-05	0.000717	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—P4HB—osteoporosis	3.03e-05	0.000716	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGA—osteoporosis	3.03e-05	0.000715	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—LEP—osteoporosis	3e-05	0.000708	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—POMC—osteoporosis	3e-05	0.000707	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—ADCY5—osteoporosis	2.98e-05	0.000704	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTH—osteoporosis	2.95e-05	0.000696	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RAP1A—osteoporosis	2.9e-05	0.000684	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CALCA—osteoporosis	2.9e-05	0.000684	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—FDPS—osteoporosis	2.88e-05	0.000679	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PKM—osteoporosis	2.88e-05	0.000679	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CNR2—osteoporosis	2.88e-05	0.000679	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ESR1—osteoporosis	2.86e-05	0.000676	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.86e-05	0.000676	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—ADCY5—osteoporosis	2.85e-05	0.000674	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IRS1—osteoporosis	2.84e-05	0.00067	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NFATC1—osteoporosis	2.83e-05	0.000668	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—POMC—osteoporosis	2.83e-05	0.000667	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTHLH—osteoporosis	2.82e-05	0.000664	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—BMP2—osteoporosis	2.82e-05	0.000664	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DKK1—osteoporosis	2.81e-05	0.000662	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—KL—osteoporosis	2.79e-05	0.000658	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGB—osteoporosis	2.76e-05	0.00065	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—POMC—osteoporosis	2.73e-05	0.000645	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PGLS—osteoporosis	2.73e-05	0.000644	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GPD2—osteoporosis	2.73e-05	0.000644	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—POMC—osteoporosis	2.72e-05	0.000642	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—WNT1—osteoporosis	2.7e-05	0.000638	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IRS1—osteoporosis	2.68e-05	0.000632	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6R—osteoporosis	2.67e-05	0.000629	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PSMA2—osteoporosis	2.66e-05	0.000628	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PSMA5—osteoporosis	2.66e-05	0.000628	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6R—osteoporosis	2.65e-05	0.000626	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KL—osteoporosis	2.63e-05	0.000621	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGA—osteoporosis	2.63e-05	0.000621	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IGF1—osteoporosis	2.63e-05	0.00062	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—ADCY5—osteoporosis	2.59e-05	0.000612	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—POMC—osteoporosis	2.58e-05	0.000608	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—POMC—osteoporosis	2.57e-05	0.000606	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6R—osteoporosis	2.51e-05	0.000593	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6R—osteoporosis	2.5e-05	0.000591	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ATIC—osteoporosis	2.5e-05	0.000589	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PNP—osteoporosis	2.5e-05	0.000589	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IGF1—osteoporosis	2.48e-05	0.000585	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CALCA—osteoporosis	2.48e-05	0.000585	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTHLH—osteoporosis	2.44e-05	0.000577	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—BMP2—osteoporosis	2.44e-05	0.000577	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—POMC—osteoporosis	2.42e-05	0.000571	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGB—osteoporosis	2.39e-05	0.000565	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PSMA2—osteoporosis	2.31e-05	0.000545	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PSMA5—osteoporosis	2.31e-05	0.000545	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KL—osteoporosis	2.25e-05	0.000531	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—POMC—osteoporosis	2.2e-05	0.000518	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADCY5—osteoporosis	2.19e-05	0.000516	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CALCA—osteoporosis	2.15e-05	0.000508	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	2.14e-05	0.000505	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—OXCT1—osteoporosis	2.12e-05	0.000501	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CA2—osteoporosis	2.12e-05	0.000501	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SPP1—osteoporosis	2.11e-05	0.000499	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—POMC—osteoporosis	2.1e-05	0.000495	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MGLL—osteoporosis	2.07e-05	0.000488	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADCY5—osteoporosis	2.06e-05	0.000486	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL6—osteoporosis	2.01e-05	0.000474	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SPP1—osteoporosis	1.99e-05	0.000471	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KL—osteoporosis	1.95e-05	0.000461	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IRS2—osteoporosis	1.91e-05	0.000451	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.91e-05	0.00045	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL6—osteoporosis	1.9e-05	0.000448	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—LEP—osteoporosis	1.87e-05	0.000442	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.86e-05	0.000439	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IRS2—osteoporosis	1.8e-05	0.000426	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.79e-05	0.000422	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—LEP—osteoporosis	1.76e-05	0.000416	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.76e-05	0.000416	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—IDH2—osteoporosis	1.76e-05	0.000415	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.71e-05	0.000403	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ESR1—osteoporosis	1.68e-05	0.000398	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.67e-05	0.000394	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.65e-05	0.00039	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ACP5—osteoporosis	1.61e-05	0.00038	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—POMC—osteoporosis	1.61e-05	0.000379	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MYC—osteoporosis	1.58e-05	0.000373	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TGFB1—osteoporosis	1.58e-05	0.000372	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IRS1—osteoporosis	1.57e-05	0.000372	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.57e-05	0.00037	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.55e-05	0.000365	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.54e-05	0.000364	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.53e-05	0.000361	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—POMC—osteoporosis	1.52e-05	0.000358	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.51e-05	0.000356	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TPI1—osteoporosis	1.5e-05	0.000353	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MYC—osteoporosis	1.49e-05	0.000352	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TGFB1—osteoporosis	1.49e-05	0.000351	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.48e-05	0.00035	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6R—osteoporosis	1.48e-05	0.000349	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IGF1—osteoporosis	1.46e-05	0.000344	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.44e-05	0.00034	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—P4HB—osteoporosis	1.41e-05	0.000332	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.38e-05	0.000326	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.35e-05	0.000318	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.34e-05	0.000317	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.34e-05	0.000316	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.31e-05	0.000309	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.3e-05	0.000306	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.26e-05	0.000299	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.25e-05	0.000295	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.25e-05	0.000294	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—osteoporosis	1.19e-05	0.00028	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—osteoporosis	1.18e-05	0.000279	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.17e-05	0.000276	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—POMC—osteoporosis	1.13e-05	0.000266	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—osteoporosis	1.12e-05	0.000264	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—osteoporosis	1.12e-05	0.000263	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.1e-05	0.000259	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ENO1—osteoporosis	1.09e-05	0.000256	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.08e-05	0.000256	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.07e-05	0.000253	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.07e-05	0.000253	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—osteoporosis	9.54e-06	0.000225	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MYC—osteoporosis	9.29e-06	0.000219	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TGFB1—osteoporosis	9.27e-06	0.000219	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MYC—osteoporosis	8.76e-06	0.000207	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TGFB1—osteoporosis	8.74e-06	0.000206	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.69e-06	0.000205	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—osteoporosis	8.28e-06	0.000196	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MYC—osteoporosis	7.5e-06	0.000177	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	7.48e-06	0.000176	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ADCY5—osteoporosis	7.1e-06	0.000167	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GPX1—osteoporosis	7.07e-06	0.000167	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—osteoporosis	6.98e-06	0.000165	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—osteoporosis	6.59e-06	0.000155	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MTHFR—osteoporosis	6.53e-06	0.000154	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MYC—osteoporosis	6.51e-06	0.000154	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	6.49e-06	0.000153	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—osteoporosis	5.63e-06	0.000133	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—POMC—osteoporosis	5.22e-06	0.000123	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—osteoporosis	4.89e-06	0.000115	CbGpPWpGaD
